Skip to content
Tenfell
Awarded contract
Published 29 Apr 2021

NHS National Generic Pharmaceuticals- Transition 2021_1

NHS England · London

Key facts

Awarded
03 Mar 2021
Contract starts
14 Apr 2021
Contract ends
30 Jun 2022
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 20 suppliers

SupplierValue
Pfizer Ltd—
Dr Reddy's Laboratories (UK) Ltd—
Martindale Pharma—
Ranbaxy (UK) Ltd—
Teva UK Ltd—
Aventis Pharma Ltd T/A Sanofi—
Selective Supplies Ltd—
Thornton & Ross Ltd—
Accord-UK Ltd—
Kent Pharma Ltd—
Amarox Limited—
Brown & Burk UK Ltd—
Day Lewis Medical Ltd—
medac Pharma LLP—
Tillomed Laboratories ltd—
Aspire Pharma Ltd—
Panpharma UK Ltd—
Ascend Laboratories UK Ltd—
Morningside Pharmaeuticals—
Aspen Pharma Ireland Ltd—

Description

NHS National PharmaceuticalsTransition 2021_1 Offer referencenumber: CM/PHG/20/5629 Period offramework agreement: the totalmaximum duration of the frameworkagreement to be no more than 29months (14.5 months plus options toextend (at the Authority's solediscretion) for up to a further 14.5months) Potential Periods of call-offsunder the framework agreementTransition and 33 % Products: CESW 15 April 2021 to 30 September2021 (5.5 months); LSNE 15 April 2021 to 28 February2022 (10.5 months); NWLN 15 April 2021 to 30 June 2022(14.5 months); 100 % Products (All Regions): 15 April2021 to 28 February 2022 (10.5months).

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.